Latest Breaking News On - Sage therapeutic - Page 6 : comparemela.com

Zuranolone cleared for post-partum depression, but not MDD

Zuranolone cleared for post-partum depression, but not MDD
pharmaphorum.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmaphorum.com Daily Mail and Mail on Sunday newspapers.

Chris-viehbacher
Drug-enforcement-administration
Sage-therapeutic

Sage Stock: Why The Biotech Lost Half Its Value After The FDA Approved Its Depression Drug

Sage Stock: Why The Biotech Lost Half Its Value After The FDA Approved Its Depression Drug
investors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investors.com Daily Mail and Mail on Sunday newspapers.

Drug-administration
Sage-therapeutic

Zevra Therapeutics (ZVRA) Appoints Thomas Anderson to Board of Directors and Announces Retirement of Matthew R. Plooster

Zevra Therapeutics (ZVRA) Appoints Thomas Anderson to Board of Directors and Announces Retirement of Matthew R. Plooster
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Philadelphia
Pennsylvania
United-states
Tom-anderson
Matthewr-plooster
Tamaraa-seymour-favorito
Company-on
Sage-therapeutics-inc
Claneil-enterprises-inc
Shire-pharmaceuticals-group
Zevra-therapeutics
Swanbio-therapeutics

Updated News -FDA Approves Biogen-Sage Pill for Postpartum Depression

The U.S. Food and Drug Administration (FDA) has granted approval for Biogen and Sage Therapeutics' oral pill, Zurzuvae, to treat postpartum depression (PPD) in adults. This milestone came after the companies sought FDA approval for the drug, intending to address both major depressive disorder (MDD) and postpartum depression, conditions that impact a significant number of…

United-states
Us-drug-enforcement-administration
Drug-administration
Sage-therapeutic
Sage-therapeutics
Enforcement-administration
Complete-response-letter
New-drug-application

U.S. FDA approves oral pill for postpartum depression

The U.S. Food and Drug Administration (FDA) on Friday approved Biogen BIIB.O and Sage Therapeutics SAGE.O oral pill to treat postpartum depression (PPD) in adults.

United-states
Us-drug-enforcement-administration
Drug-administration
Sage-therapeutic
Enforcement-administration
Complete-response-letter
New-drug-application